A pair of clinical forums examined new CKM staging, SGLT2 and MRA trial data, and the barriers delaying heart failure treatment.
Back
Beyond the EF: Heart Failure Management in 2026
An expert clinical forum series discussing guidelines, access, collaborative care and more on heart failure.
Beyond the EF: Heart Failure Management in 2026
Episodes
All
All
Ronald D'Agostino, DO, discusses the 2026 HFpEF pathway, H2FPEF screening, and comorbidity-first heart failure care.
Remick discusses multidisciplinary teams, adherence issues, and the path forward for heart failure care in this post-forum interview.
Advertisement
Advertisement
Trending on HCPLive
1
The Case for Routine Kidney Screening, With Pranav Garimella, MBBS, MPH
2
FDA Approves Obinutuzumab (Gazyva) for Idiopathic Nephrotic Syndrome
3
Zilurgisertib Receives FDA Approval for FOP in Patients 12 and Older
4
Anti-Alpha-Gal Antibodies Block IgE Binding in Alpha-Gal Syndrome
5